1 Src family kinases and paclitaxel sensitivity
来源:CANCER BIOL THER( P 1538-4047 E 1555-8576 ) 发表时间: 2011/08
类型:期刊论文 为本人加分:7418.148776
2 The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade
来源:CANCER MICROENVIRON( P 1875-2292 E 1875-2284 ) 发表时间: 2010/12
类型:期刊论文 为本人加分:6569.236961
3 Dasatinib Induces Autophagic Cell Death in Human Ovarian Cancer
来源:CANCER-AM CANCER SOC( P 0008-543X E ) 发表时间: 2010/11
类型:期刊论文 为本人加分:6130.915987
4 Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast Cancer
来源:PLOS ONE( P 1932-6203 E ) 发表时间: 2012/07
类型:期刊论文 为本人加分:5138.025516
5 Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xe..
来源:CELL CYCLE( P 1538-4101 E 1551-4005 ) 发表时间: 2008/12
类型:期刊论文 为本人加分:5082.228643
6 The Role of p27(Kip1) in Dasatinib-Enhanced Paclitaxel Cytotoxicity in Human Ovarian Cancer Cells
来源:JNCI-J NATL CANCER I( P 0027-8874 E 1460-2105 ) 发表时间: 2011/09
类型:期刊论文 为本人加分:4990.024740
7 Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kin..
来源:MOL CANCER THER( P 1535-7163 E 1538-8514 ) 发表时间: 2007/11
类型:期刊论文 为本人加分:3896.395467
8 Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pa..
来源:CELL CYCLE( P 1538-4101 E 1551-4005 ) 发表时间: 2006/08
类型:期刊论文 为本人加分:2439.145021
9 CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1-..
来源:PLOS ONE( P 1932-6203 E ) 发表时间: 2015/07
类型:期刊论文 为本人加分:1692.151707
10 Clinically Relevant microRNAs in Ovarian Cancer
来源:MOL CANCER RES( P 1541-7786 E 1557-3125 ) 发表时间: 2015/03
类型:期刊论文 为本人加分:1360.325769